The Imcyse journey began when the founders discovered the ability of certain peptides to stimulate the immune system in a new way. After further investigation they invented new peptides, called ImotopesTM and showed these could induce a special type of T cell (cytolytic CD4+ T cell) that breaks the chain of events leading to severe autoimmune disease.
The carefully designed synthetic peptides, ImotopesTM, stimulate T cells to develop into a new phenotype which in turn can control the disease inflammatory processes and autoimmune attack. While many current therapies for autoimmune diseases trigger a general suppression of the immune system, this discovery allows the body’s own immune system to delete only the cells that drive abnormal immune attack but leave the rest of the immune system functioning normally. This stops tissue and organ damage and disease progression and can create a favorable environment for potential healing of the damaged organ.